Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238–52.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294–304.
Article CAS PubMed PubMed Central Google Scholar
Wouk N. End-stage renal disease: medical management. Am Fam Physician. 2021;104:493–9.
Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res. 2008;31:1101–7.
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, et al. Chronic kidney disease. Nat Rev Dis Primers. 2017;3:17088.
Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023;132:1050–63.
Article CAS PubMed Google Scholar
Sun K, Lin D, Feng Q, Li F, Qi Y, Huang C, et al. Parity is associated with albuminuria and chronic kidney disease: a population-based study. Aging (Albany NY). 2019;11:11030–9.
Article CAS PubMed PubMed Central Google Scholar
Moazzeni SS, Asgari S, Azizi F, Hadaegh F. Live birth/parity number and the risk of incident hypertension among parous women during over 13 years of follow-up. J Clin Hypertens (Greenwich). 2021;23:2000–8.
Article PubMed PubMed Central Google Scholar
Guo P, Zhou Q, Ren L, Chen Y, Hui Y. Higher parity is associated with increased risk of Type 2 diabetes mellitus in women: A linear dose-response meta-analysis of cohort studies. J Diabetes Complications. 2017;31:58–66.
Huayanay-Espinoza CA, Quispe R, Poterico JA, Carrillo-Larco RM, Bazo-Alvarez JC, Miranda JJ. Parity and overweight/obesity in Peruvian women. Prev Chronic Dis. 2017;14:E102.
Article PubMed PubMed Central Google Scholar
Ohashi M, Miura K, Takashima N, Kadota A, Saito Y, Tsuji S, et al. The association of reproductive history with hypertension and obesity according to menopausal status: the J-MICC Study. Hypertens Res. 2022;45:708–14.
Oishi M, Iino K, Tanaka K, Ishihara K, Yokoyama Y, Takahashi I, et al. Hypertensive disorders of pregnancy increase the risk for chronic kidney disease: A population-based retrospective study. Clin Exp Hypertens. 2017;39:361–5.
Article CAS PubMed Google Scholar
Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997–2008. Diabetes Care. 2011;34:353–7.
Article PubMed PubMed Central Google Scholar
Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health. 2003;45:335–43.
Kuriyama S, Yaegashi N, Nagami F, Arai T, Kawaguchi Y, Osumi N, et al. The Tohoku Medical Megabank Project: Design and Mission. J Epidemiol. 2016;26:493–511.
Hozawa A, Tanno K, Nakaya N, Nakamura T, Tsuchiya N, Hirata T, et al. Study profile of the Tohoku medical megabank community-based cohort study. J Epidemiol. 2021;31:65–76.
Article PubMed PubMed Central Google Scholar
Vellanki K, Hou S. Menopause in CKD. Am J Kidney Dis. 2018;71:710–9.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197–203.
Article CAS PubMed Google Scholar
Wagata M, Kogure M, Nakaya N, Tsuchiya N, Nakamura T, Hirata T, et al. Hypertensive disorders of pregnancy, obesity, and hypertension in later life by age group: a cross-sectional analysis. Hypertens Res. 2020;43:1277–83.
Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.
Toloza FJK, Derakhshan A, Männistö T, Bliddal S, Popova PV, Carty DM, et al. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2022;10:243–52.
Article CAS PubMed PubMed Central Google Scholar
Itabashi F, Hirata T, Kogure M, Narita A, Tsuchiya N, Nakamura T, et al. Combined associations of liver enzymes and obesity with diabetes mellitus prevalence: the Tohoku medical megabank community-based cohort study. J Epidemiol. 2022;32:221–7.
Article PubMed PubMed Central Google Scholar
Ikai E, Noborizaka Y, Tsuritani I, Honda R, Ishizaki M, Yamada Y. Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension. Obes Res. 1993;1:469–74.
Article CAS PubMed Google Scholar
Borrelli S, Provenzano M, Gagliardi I, Michael A, Liberti ME, De Nicola L, et al. Sodium intake and chronic kidney disease. Int J Mol Sci. 2020;21:4744.
Article CAS PubMed PubMed Central Google Scholar
Gilligan S, Raphael KL. Hyperkalemia and hypokalemia in CKD: prevalence, risk factors, and clinical outcomes. Adv Chronic Kidney Dis. 2017;24:315–8.
Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97–103.
Article CAS PubMed Google Scholar
Tasevska N, Runswick SA, Bingham SA. Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. J Nutr. 2006;136:1334–40.
Taghdir M, Alimohamadi Y, Sepandi M, Rezaianzadeh A, Abbaszadeh S, Mahmud FM. Association between parity and obesity: a cross sectional study on 6,447 Iranian females. J Prev Med Hyg. 2020;61:E476–81.
PubMed PubMed Central Google Scholar
Woodward M. Epidemiology: Study Design and Data Analysis. 3rd ed. New York: Chapman and Hall/CRC; 2014.
Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria; 2021.
Barrett PM, McCarthy FP, Evans M, Kublickas M, Perry IJ, Stenvinkel P, et al. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study. PLoS Med. 2020;17:e1003255.
Article PubMed PubMed Central Google Scholar
Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ. 2023;381:e071653.
Ponticelli C, Moroni G. Is preeclampsia a risk for end-stage renal disease? Kidney Int. 2019;96:547–9.
White WM, Garrett AT, Craici IM, Wagner SJ, Fitz-Gibbon PD, Butters KA, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One. 2014;9:e92693.
Article PubMed PubMed Central Google Scholar
Khashan AS, Evans M, Kublickas M, McCarthy FP, Kenny LC, Stenvinkel P, et al. Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med. 2019;16:e1002875.
Article PubMed PubMed Central Google Scholar
Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita ATN. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Curr Hypertens Rep. 2020;22:66.
Article PubMed PubMed Central Google Scholar
Li G, Wei W, Suo L, Zhang C, Yu H, Liu H, et al. Low-Dose aspirin prevents kidney damage in LPS-induced preeclampsia by inhibiting the WNT5A and NF-κB signaling pathways. Front Endocrinol (Lausanne). 2021;12:639592.
Article PubMed PubMed Central Google Scholar
Chintam K, Chang AR. Strategies to treat obesity in patients with CKD. Am J Kidney Dis. 2021;77:427–39.
Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol. 1982;116:114–22.
Article CAS PubMed Google Scholar
Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45:1298–309.
留言 (0)